Literature DB >> 1873851

Cytogenetics of human malignant melanoma.

J M Trent1.   

Abstract

There has been a tremendous recent resurgence of interest in examining chromosomal abnormalities in human cancers (particularly solid tumors). This interest has been stimulated by the molecular examination of recurring chromosome abnormalities, and the recognition that they may pinpoint the location of growth regulatory sequences (e.g. cellular oncogenes). This finding coupled with the clear recognition that specific chromosome abnormalities can also have important diagnostic and prognostic implications, have caused this avenue of research to expand at a significant rate. The following brief review will summarize the current state of knowledge regarding recurring chromosome abnormalities in human malignant melanoma. A discussion of chromosome changes in pre-malignant skin lesions, primary melanoma, and metastatic melanoma is described. Brief descriptions of the potential clinical utility, and biologic relevance of chromosome abnormalities in this disorder are also discussed.

Entities:  

Mesh:

Year:  1991        PMID: 1873851     DOI: 10.1007/bf00049408

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  44 in total

Review 1.  Report of the committee on chromosome changes in neoplasia.

Authors:  F Mitelman; Y Kaneko; J M Trent
Journal:  Cytogenet Cell Genet       Date:  1990

2.  Differential staining of the satellite regions of human acrocentric chromosomes.

Authors:  W M Howell; T E Denton; J R Diamond
Journal:  Experientia       Date:  1975-02-15

3.  A metastatic malignant melanoma with 24 chromosomes.

Authors:  N B Atkin; M C Baker
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

4.  Allele losses in malignant melanoma reflect random events.

Authors:  M Nordenskjöld; B Werelius; U Ringborg
Journal:  Anticancer Res       Date:  1990 Jul-Aug       Impact factor: 2.480

5.  Involvement of chromosome 6 in rearrangements in human malignant melanoma cell lines.

Authors:  S Pathak; H L Drwinga; T C Hsu
Journal:  Cytogenet Cell Genet       Date:  1983

6.  Multiple karyotypic abnormalities, including structural rearrangements of 11p, in cell lines from malignant melanomas.

Authors:  S Heim; N Mandahl; K Arheden; B C Giovanella; S O Yim; J S Stehlin; F Mitelman
Journal:  Cancer Genet Cytogenet       Date:  1988-10-01

7.  Chromosome changes in metastatic human melanoma.

Authors:  J Limon; P Dal Cin; S N Sait; C Karakousis; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1988-02

8.  Possible involvement of the chromosome region 10q24----q26 in early stages of melanocytic neoplasia.

Authors:  A H Parmiter; G Balaban; W H Clark; P C Nowell
Journal:  Cancer Genet Cytogenet       Date:  1988-02

9.  Chromosomal localization of human leukocyte, fibroblast, and immune interferon genes by means of in situ hybridization.

Authors:  J M Trent; S Olson; R M Lawn
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6.

Authors:  J M Trent; E J Stanbridge; H L McBride; E U Meese; G Casey; D E Araujo; C M Witkowski; R B Nagle
Journal:  Science       Date:  1990-02-02       Impact factor: 47.728

View more
  3 in total

1.  Functional analysis and molecular targeting of aurora kinases a and B in advanced melanoma.

Authors:  Xiaolei Wang; Stergios J Moschos; Dorothea Becker
Journal:  Genes Cancer       Date:  2010-09

Review 2.  Malignant melanoma in the 21st century: the emerging molecular landscape.

Authors:  Aleksandar Sekulic; Paul Haluska; Arlo J Miller; Josep Genebriera De Lamo; Samuel Ejadi; Jose S Pulido; Diva R Salomao; Erik C Thorland; Richard G Vile; David L Swanson; Barbara A Pockaj; Susan D Laman; Mark R Pittelkow; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2008-07       Impact factor: 7.616

Review 3.  Oxygen in human health from life to death--An approach to teaching redox biology and signaling to graduate and medical students.

Authors:  Margaret M Briehl
Journal:  Redox Biol       Date:  2015-04-11       Impact factor: 11.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.